发明名称 |
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer |
摘要 |
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine are disclosed for use in the treatment of cancer, especially in the treatment of cancer where the patient shows resistance, for example, in a patient with cells with a lowered level of nucleoside transporter proteins and/or with nucleoside kinase-deficient cells and/or with mycoplasma-infected cells and/or with cells with a raised level of thymidylate synthase.; |
申请公布号 |
US8933053(B2) |
申请公布日期 |
2015.01.13 |
申请号 |
US201214000682 |
申请日期 |
2012.02.29 |
申请人 |
NuCana BioMed Limited |
发明人 |
McGuigan Christopher;Balzarini Jan;Slusarczyk Magdalena;Gonczy Blanka;Murziani Paola |
分类号 |
A61K31/7072;A61K45/06;C07H19/10;C07F9/6584;C07F9/655;C07F9/6558 |
主分类号 |
A61K31/7072 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A compound which is 5-fluoro-2′-deoxyuridine-5′-O-[1-naphthyl(benzoxy-L-alaninyl)]phosphate (CPF373), or a pharmaceutically acceptable salt or metabolite thereof. |
地址 |
Camberley GB |